CLINICAL STUDIES
Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease
Effects of continuous positive air pressure treatment
Nir Peled, MD*  ,
Edward G. Abinader, MD,
Giora Pillar, MD, DSc*,
Dawood Sharif, MD and
Peretz Lavie, PhD*
* Sleep Laboratory, Technion-Israel Institute of Technology, Haifa, Israel
Heart Institute, ‘Bnei-Zion’ Medical Center, Haifa, Israel
Manuscript received August 24, 1998;
revised manuscript received June 15, 1999,
accepted August 6, 1999.
Reprint requests and correspondence: P. Lavie, Sleep Laboratory, Gutwirth Building, Technion-Israel Institute of Technology, Haifa, Israel 32000
plavie{at}techunixtechnion.ac.il
OBJECTIVES
To investigate the occurrence of nocturnal ischemic events in patients with obstructive sleep apnea syndrome (OSAS) and ischemic heart disease (IHD).
BACKGROUND
Although previous reports documented nocturnal cardiac ischemic events among OSAS patients, the exact association between obstructive apneas and ischemia is not yet clear. It is also not known what differentiates between patients showing nocturnal ischemia and those that do not.
METHODS
Fifty-one sleep apnea patients (age 61.3 ± 8.3) with IHD participated in the study (after withdrawal of beta-adrenergic blocking agents and anti-anginotic treatment). All patients underwent whole-night polysomnography including ambulatory blood pressure recordings (30 min interval) and continuous Holter monitoring during sleep. A control group of 17 OSAS patients free from IHD were also similarly studied. Fifteen of the 51 patients were also recorded under continuous positive airway pressure (CPAP).
RESULTS
Nocturnal ST segment depression occurred in 10 patients (a total of 15 events, 182 min), of whom six also had morning ischemia (06–08 am). Five additional patients had only morning ischemia. No ischemic events occurred in the control group. Age, sleep efficiency, oxygen desaturation, IHD severity and nocturnal-double product (DP) values were the main variables that significantly differentiated between patients who had ischemic events during sleep and those who did not. Nocturnal ischemia predominantly occurred during the rebreathing phase of the obstructive apneas, and it is characterized by increased heart rate (HR) and DP values. Treatment with continuous positive airway pressure significantly ameliorated the nocturnal ST depression time from 78 min to 33 min (p < 0.001) as well as the maximal DP values (14,137 ± 2,827 vs. 12,083 ± 2,933, p < 0.001).
CONCLUSIONS
Exacerbation of ischemic events during sleep in OSAS may be explained by the combination of increased myocardial oxygen consumption as indicated by increased DP values and decreased oxygen supply due to oxygen desaturation with peak hemodynamic changes during the rebreathing phase of the obstructive apnea. Treatment with CPAP ameliorated the nocturnal ischemia.
|
Abbreviations and Acronyms
| | AHI | = apnea hypopnea index | | ANOVA | = analysis of variance | | BP | = blood pressure | | CPAP | = continuous positive air pressure | | DP | = double product | | HR | = heart rate | | IHD | = ischemic heart disease | | MI | = myocardial infarction | | OSAS | = obstructive sleep apnea syndrome | | REM | = rapid eye movement | | SaO2 | = oxygen saturation | | VD | = vessel disease |
|
This article has been cited by other articles:
|
|
|
|
 
C.-H. Lee, S.-M. Khoo, B.-C. Tai, E. Y. Chong, C. Lau, Y. Than, D.-X. Shi, L.-C. Lee, A. Kailasam, A. F. Low, et al.
Obstructive Sleep Apnea in Patients Admitted for Acute Myocardial Infarction: Prevalence, Predictors, and Effect on Microvascular Perfusion
Chest,
June 1, 2009;
135(6):
1488 - 1495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Circulation,
September 2, 2008;
118(10):
1080 - 1111.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
J. Am. Coll. Cardiol.,
August 19, 2008;
52(8):
686 - 717.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Hwang, N. Shakir, B. Limann, C. Sison, S. Kalra, L. Shulman, A. d. C. Souza, and H. Greenberg
Association of Sleep-Disordered Breathing With Postoperative Complications
Chest,
May 1, 2008;
133(5):
1128 - 1134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Lopez-Jimenez, F. H. Sert Kuniyoshi, A. Gami, and V. K. Somers
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
Chest,
March 1, 2008;
133(3):
793 - 804.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez
Pulmonary Diseases and the Heart
Circulation,
December 18, 2007;
116(25):
2992 - 3005.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. T. McNicholas
Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2007;
293(4):
R1666 - R1670.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-M. Park and Y. J. Suzuki
Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice
J Appl Physiol,
May 1, 2007;
102(5):
1806 - 1814.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Eur. Respir. J.,
January 1, 2007;
29(1):
156 - 178.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Nakashima, T. Katayama, C. Takagi, K. Amenomori, M. Ishizaki, Y. Honda, and S. Suzuki
Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction
Eur. Heart J.,
October 1, 2006;
27(19):
2317 - 2322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kaw, F. Michota, A. Jaffer, S. Ghamande, D. Auckley, and J. Golish
Unrecognized Sleep Apnea in the Surgical Patient: Implications for the Perioperative Setting
Chest,
January 1, 2006;
129(1):
198 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sakurai, T. Nishijima, S. Takahashi, K. Yamauchi, Z. Arihara, and K. Takahashi
Low Plasma Orexin-A Levels Were Improved by Continuous Positive Airway Pressure Treatment in Patients With Severe Obstructive Sleep Apnea-Hypopnea Syndrome
Chest,
March 1, 2005;
127(3):
731 - 737.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Feinsilver
A Sleeping Giant: Sleep-Disordered Breathing in the Coronary Care Unit
Chest,
January 1, 2005;
127(1):
4 - 5.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Alonso-Fernandez, F. Garcia-Rio, M. A. Racionero, J. M. Pino, F. Ortuno, I. Martinez, and J. Villamor
Cardiac Rhythm Disturbances and ST-Segment Depression Episodes in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome and Its Mechanisms
Chest,
January 1, 2005;
127(1):
15 - 22.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Parish and V. K. Somers
Obstructive Sleep Apnea and Cardiovascular Disease
Mayo Clin. Proc.,
August 1, 2004;
79(8):
1036 - 1046.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. S. Gami, A. Svatikova, R. Wolk, E. J. Olson, C. J. Duenwald, A. S. Jaffe, and V. K. Somers
Cardiac Troponin T in Obstructive Sleep Apnea
Chest,
June 1, 2004;
125(6):
2097 - 2100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Milleron, R. Pilliere, A. Foucher, F. de Roquefeuil, P. Aegerter, G. Jondeau, B. G Raffestin, and O. Dubourg
Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study
Eur. Heart J.,
May 1, 2004;
25(9):
728 - 734.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo Jr, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright Jr, et al.
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Hypertension,
December 1, 2003;
42(6):
1206 - 1252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. M. Shamsuzzaman, B. J. Gersh, and V. K. Somers
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
JAMA,
October 8, 2003;
290(14):
1906 - 1914.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. o-D. L. Lattimore, D. S. Celermajer, and I. Wilcox
Obstructive sleep apnea and cardiovascular disease
J. Am. Coll. Cardiol.,
May 7, 2003;
41(9):
1429 - 1437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. T. LEUNG and T. DOUGLAS BRADLEY
Sleep Apnea and Cardiovascular Disease
Am. J. Respir. Crit. Care Med.,
December 15, 2001;
164(12):
2147 - 2165.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Mutlu and I. Rubinstein
Obstructive Sleep Apnea Syndrome-Associated Nocturnal Myocardial Ischemia
Chest,
June 1, 2000;
117(6):
1534 - 1535.
[Full Text]
[PDF]
|
|
|
|
